A comparison of patient-reported outcome measures following technical success and technical failure in the treatment of great saphenous vein incompetence using ClariVein: A subanalysis of a multicenter randomized controlled trial comparing 2% and 3% polidocanol
Phlebology: The Journal of Venous Disease · 2023
DOI: 10.1177/02683555231189414 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Phlebology: The Journal of Venous Disease, 2023. Verfasst von Tamana Alozai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Northwest Clinics, Alkmaar, the Netherlands. Hauptthemen laut MEDLINE: Endovascular Procedures, Varicose Veins, Venous Insufficiency. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Vascular Insights.
Abstract (Originalsprache)
Objective
This study aimed to compare patient-reported outcomes after technical success (TS) and technical failure (TF) in treating great saphenous vein incompetence (GSV) with ClariVein.
Methods
A subanalysis of a previous trial was conducted on symptomatic GSV incompetence patients who received ClariVein treatment with 2% or 3% polidocanol (POL) and were followed for 6 months. Blinding was implemented for observers and patients, and data from both POL groups were combined. TS was defined as at least 85% occlusion of the treated vein, while TF indicated failure to meet TS criteria. Secondary outcomes included Venous Clinical Severity Score (VCSS), Aberdeen Varicose Vein Questionnaire (AVVQ), and Short-Form 36 Health Survey Questionnaire (SF-36).
Results
Among the 364 patients included, the TS rate was 64.5%. Comparison of VCSS, AVVQ, and SF-36 scores between TS and TF groups did not yield significant differences.
Conclusion
This study indicates no significant variation in VCSS, AVVQ, and SF-36 scores between patients experiencing TS and TF following ClariVein treatment for GSV insufficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Northwest Clinics, Alkmaar, the Netherlands.
- Department of Surgery, Amsterdam University Medical Center, Amsterdam, the Netherlands.
- Department of Dermatology, Zaans Medisch Centrum, Zaandam, the Netherlands.
- Department of Surgery, Red Cross Hospital, Beverwijk, the Netherlands.
- Department of Vascular Surgery, Maasstad Hospital, Rotterdam, the Netherlands.
- Department of Vascular Surgery, OLVG, Amsterdam, the Netherlands.
ORCID-Profile: Tamana Alozai
Förderung
- Vascular Insights
Zitieren
APA
Alozai, T., Lam, Y. L., Schreve, M. A., de Smet, A. A., Vahl, A. C., Terlouw-Punt, L. C., Ünlü, Ç., & Wittens, C. H. (2023). A comparison of patient-reported outcome measures following technical success and technical failure in the treatment of great saphenous vein incompetence using ClariVein: A subanalysis of a multicenter randomized controlled trial comparing 2% and 3% polidocanol. Phlebology: The Journal of Venous Disease. https://doi.org/10.1177/02683555231189414
Vancouver
Alozai T, Lam YL, Schreve MA, de Smet AA, Vahl AC, Terlouw-Punt LC, et al. A comparison of patient-reported outcome measures following technical success and technical failure in the treatment of great saphenous vein incompetence using ClariVein: A subanalysis of a multicenter randomized controlled trial comparing 2% and 3% polidocanol. Phlebology: The Journal of Venous Disease. 2023. doi:10.1177/02683555231189414
BibTeX
@article{Alozai2023,
author = {Alozai, Tamana and Lam, Yee Lai and Schreve, Michiel A and de Smet, André Aea and Vahl, Anco C and Terlouw-Punt, Liesbeth C and Ünlü, Çağdaş and Wittens, Cees Ha},
title = {A comparison of patient-reported outcome measures following technical success and technical failure in the treatment of great saphenous vein incompetence using ClariVein: A subanalysis of a multicenter randomized controlled trial comparing 2% and 3% polidocanol},
journal = {Phlebology: The Journal of Venous Disease},
year = {2023},
doi = {10.1177/02683555231189414}
}
EUVIMED